BNC Korea KRX:256840KOSDAQ
한국비엔씨 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days1
DART filings, 7 days0
Articles tracked26since Sep 11
In Q2 2026, BNC Korea reported revenue of ₩24.6bn, down 0.1% year on year, and an operating loss of ₩366m. BNC Korea (한국비엔씨) appeared in 1 Korean news article and 0 DART filings over the past seven days. Coverage peaked on Oct 20 with 1 article. The most common catalyst was tech & capacity (1).
Filing signals Swung to loss 4 quarters of losses Share pledge Screener
BNC Korea quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩24.6bn | -0.1% | −₩366m margin −1.5% | −₩1.7bn |
| Q1 2026 | ₩20.7bn | -18.4% | −₩1.5bn margin −7.1% | −₩1.3bn |
| Q4 2025 derived | ₩23.6bn | -8.6% | −₩2.4bn margin −10.0% | −₩3.0bn |
| Q3 2025 | ₩22.3bn | -5.2% | −₩1.4bn margin −6.3% | −₩366m |
| Q2 2025 | ₩24.6bn | +8.4% | ₩1.6bn margin 6.5% | ₩281m |
| Q1 2025 | ₩25.4bn | +47.6% | ₩3.8bn margin 14.9% | ₩5.1bn |
| Q4 2024 derived | ₩25.8bn | +9.9% | ₩1.7bn margin 6.7% | ₩8.6bn |
| Q3 2024 | ₩23.5bn | +15.3% | ₩3.4bn margin 14.5% | ₩1.8bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
BNC Korea top stories 2 weeks, by number of outlets
- 1
- 2
Latest BNC Korea news Korean headlines
-
Major국민바이오·한국비엔씨, 근감소 신약 2종 공동개발 착수
1 more on this story · 1 outlets
- 한국비엔씨·국민바이오, 비만 근감소증 신약 2종 공동개발PRESS9 · Oct 15 14:00
-
Major한국비엔씨, 덱시부프로펜 주사제 중국 특허 확보
4 more on this story · 4 outlets
- 한국비엔씨, 덱시부프로펜 액상 주사제 中 특허 등록머니투데이 · Oct 14 11:44
- 한국비엔씨, 덱시부프로펜 액상 주사제 중국 특허 등록바이오타임즈 · Oct 14 12:03
- 한국비엔씨, 덱시부프로펜 액상 주사제 중국 특허 등록…전문의약품 사업 강화메디컬투데이 · Oct 14 15:06
- 한국비엔씨, '덱시부프로펜' 액상 주사제 중국 특허 등록히트뉴스 · Oct 14 15:38
-
투심 돌아왔다… HLB·뷰노·한국비엔씨 변곡점 중심[바이오맥짚기]
1 more on this story · 1 outlets
- 투심 돌아왔다… HLB·뷰노·한국비엔씨 변곡점 중심[바이오맥짚기]이데일리 · Sep 30 08:01